Yes, Warm Crystallized Mannitol Before Administration
If crystals are observed in mannitol solution, the container should be warmed to redissolve the crystals, then cooled to body temperature before administering 1. This is explicit FDA guidance that must be followed.
Critical Safety Requirements
The FDA drug label provides clear instructions for handling crystallized mannitol 1:
- Warm the bottle in hot water at 80°C and periodically shake vigorously to dissolve crystals
- Cool to body temperature or less before administering
- Use a filter in the administration set when infusing 25% mannitol concentrations
- Do not infuse mannitol solution if crystals are present (without first warming and redissolving)
Why Crystallization Occurs
Mannitol solutions, especially concentrations greater than 10% w/v (including the commonly used 20-25% solutions), are prone to crystallization when exposed to low temperatures 1, 2. This is a well-known stability issue with mannitol formulations that can occur at any time—whether during storage or even during a medical procedure 2.
The Warming Process
The warming and redissolution process is safe and does not compromise the medication 3:
- Mannitol 25% remains stable after repeated autoclavings at 250°F for 15 minutes 3
- The product may be repeatedly heated or autoclaved if crystals appear 3
- No chemical degradation occurs with appropriate warming
Clinical Context
When using mannitol for its primary indications—treating increased intracranial pressure or brain herniation—timing is critical 4. The recommended infusion time is 15-20 minutes at doses around 250 mOsm (typically 0.25-1 g/kg) 4. Do not delay treatment by attempting to use crystallized solution; take the time to properly warm and redissolve first, as administering crystallized solution risks vascular complications and ineffective therapy.
Common Pitfall to Avoid
Never attempt to infuse mannitol with visible crystals, even through a filter. While filters are required for 25% mannitol administration 1, they are meant to catch particulates during normal infusion, not to substitute for proper preparation of crystallized solutions. The crystals must be fully redissolved before the solution enters the administration set.